Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention

Annals of the Rheumatic Diseases

Volumn 60, Issue 9, 2001, Pages 834-840

  Angst, F ^a   Aeschlimann, A ^a   Steiner, W ^b   Stucki, G ^c  

^a Clinic of Rheumatology and Rehabilitation Zurzach   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COXITIS; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; SCORING SYSTEM; SHORT FORM-36; TREATMENT OUTCOME; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PHYSICAL THERAPY MODALITIES; PROSPECTIVE STUDIES; PSYCHOMETRICS; SENSITIVITY AND SPECIFICITY; SEX FACTORS;

EID: 0034883324     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Therapeutic targets in osteoarthritis
2. Outcome measurement in osteoarthritis clinical trials
3. Guidelines for testing slow acting drugs in osteoarthritis (SYSADOAs)
4. Comparison of a generic (SF-36) and a disease specific (WOMAC) instrument in the measurement of outcomes after knee replacement surgery
5. Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming 'chondromodulating' activity
6. Generic and disease-specific measures in assessing health status and quality of life
7. A preliminary evaluation of the dimensionality, and clinical importance of pain and disability in osteoarthritis of the hip and knee
8. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee
9. Pain assessment in osteoarthritis: Experience with the WOMAC osteoarthritis index
10. Signal measurement strategies: Are they feasible and do they offer any advantage in outcome measurement in osteoarthritis?
11. Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): Post validation reapplication of the WOMAC osteoarthritis index
12. Evaluation of a German version of the WOMAC (Western Ontario and McMaster Universities) osteoarthritis index
13. The OMERACT filter for outcome measures in rheumatology
14. Recommendations for a core set outcome measure for future phase III clinical trials in knee, hip and hand OA. Consensus development at OMERACT III
15. The Short Form-36 is preferable to the SIP as a generic health status measure in patients undergoing elective total hip arthroplasty
16. Methods for assessing condition-specific and generic functional status outcomes after total knee replacement
17. A comparison of different indices of responsiveness
18. Comparative responsiveness of 3 functional indices in ankylosing spondylitis
19. The effect of elective total hip replacement on health-related quality of life
20. Development of criteria for osteoarthritis
21. The American College of Rheumatology criteria for the classification of osteoarthritis of the hip
22. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research
23. Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project
24. Comparative measurement sensitivity of short and longer health status instruments
25. Relative responsiveness of condition specific and generic health status measures in degenerative lumbar spinal stenosis
26. Comparisons of five health status instruments for orthopedic evaluation
27. Effect sizes for interpreting changes in health status
28. Measuring change over time: Assessing the usefulness of evaluative instruments
29. Comparing the means of two samples and determination of sample size
30. Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome
31. Generic and condition-specific outcome measures for people with osteoarthritis of the knee
32. Sample size requirements: One-way analysis of variance
33. Estimation of sample size and power for comparing two means
34. Assessment of reliability
35. A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC osteoarthritis index
36. Knee injury and osteoarthritis outcome score (KOOS) - Development of a self-administered outcome measure